Clinical Trials Browser

Phase 1/2 × LY2940680 × Clear all

NCT02530437 2023-07-10

Taladegib, Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Localized Esophageal or Gastroesophageal Junction Cancer

Phase 1/2 Terminated

7 enrolled 11 charts

Gastrointestinal

Adenocarcinoma Of Esophagus

NCT01722292 2018-12-28

A Study of LY2940680 in Small Cell Lung Cancer

Phase 1/2 Terminated

26 enrolled 19 charts

Small Cell Lung Carcinoma